ViraTherapeutics GmbH

Exlgasse 20a
Innsbruck
6020

Tel: 43-512-272061
Fax: 43-512-272061-8

Email: office@viratherapeutics.com

Show jobs for this employer

About ViraTherapeutics GmbH

ViraTherapeutics GmbH is a biotech company based in Innsbruck, Tyrol, Austria. The company was formed as a spin-off of the Medical University of Innsbruck in April 2013.
ViraTherapeutics develops highly potent anti-cancer therapeutics based on oncolytic (cancer-destroying) viruses. Our proprietary oncolytic virus, VSV-GP, efficiently destroys cancer cells, while leaving normal tissues unharmed.
ViraTherapeutics currently performs preclinical safety and efficacy studies for VSV-GP and aims to conduct first clinical trials in cancer patients in 2018 at the earliest.
ViraTherapeutics is funded by JITU-Seedfinancing of the BMWFW executed by aws.
YEAR FOUNDED:
April 2013
LEADERSHIP:
Founder: George Church
CEO: Shawn Marcell
TECHNOLOGY:
Please click here for ViraTherapeutics's technology.
JOBS:
Please click here for ViraTherapeutics job opportunities.

5 articles with ViraTherapeutics GmbH